Anlon Healthcare Ltd vs Arvee Laboratories India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 22, 2026

Key Highlights

The Latest Trading Price of Anlon Healthcare Ltd is ₹ 121.35 as of 20 Mar 15:30 . The P/E Ratio of Anlon Healthcare Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Arvee Laboratories (India) Ltd changed from 22.8 on March 2021 to 72.8 on March 2025 . This represents a CAGR of 26.14% over 5 years The Market Cap of Anlon Healthcare Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Arvee Laboratories (India) Ltd changed from ₹ 61.05 crore on March 2021 to ₹ 156.47 crore on March 2025 . This represents a CAGR of 20.71% over 5 years The revenue of Anlon Healthcare Ltd for the Dec '25 is ₹ 35.78 crore as compare to the Sep '25 revenue of ₹ 52.23 crore. This represent the decline of -31.5% The revenue of Arvee Laboratories (India) Ltd for the Dec '25 is ₹ 9.92 crore as compare to the Sep '25 revenue of ₹ 3.68 crore. This represent the growth of 169.57% The ebitda of Anlon Healthcare Ltd for the Dec '25 is ₹ 12.54 crore as compare to the Sep '25 ebitda of ₹ 13.77 crore. This represent the decline of -8.93% The ebitda of Arvee Laboratories (India) Ltd for the Dec '25 is ₹ 1.76 crore as compare to the Sep '25 ebitda of ₹ 0.36 crore. This represent the growth of 388.89% The net profit of Anlon Healthcare Ltd changed from ₹ 4.54 crore to ₹ 5.15 crore over 7 quarters. This represents a CAGR of 7.47% The net profit of Arvee Laboratories (India) Ltd changed from ₹ 0.94 crore to ₹ 1.83 crore over 7 quarters. This represents a CAGR of 46.33% The Dividend Payout of Anlon Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Arvee Laboratories (India) Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Anlon Healthcare Ltd

Anlon Healthcare Limited was originally incorporated as 'Anlon Ventures Private Limited', dated November 19, 2013 issued by the RoC. The Company changed the name from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited' and a fresh Certificate of Incorporation dated May 27, 2015 was issued by the RoC. The status of the Company was subsequently converted to a Public Limited and the name of the Company was changed to 'Anlon Healthcare Limited' dated September 2, 2024 by the RoC. Anlon Healthcare is engaged in manufacturing of Pharma Intermediates and APIs.
They are one of the few manufacturers of loxoprofen sodium dihydrate in India, a notable API , widely used in treatment of pain/inflammation association with conditions including rheumatoid arthritis, osteoarthritis, lower back pain, frozen shoulder, neck-shoulder-arm syndrome, tooth pain or after surgery, injury or tooth extraction.

About Arvee Laboratories (India) Ltd

Arvee Laboratories (India) Limited was incorporated as a Private Limited Company with the name 'Arvee Laboratories (India) Private Limited' on January 27, 2012 in Ahmedabad, Gujarat.
Subsequently, the Company name was changed to Arvee Laboratories (India) Limited upon conversion into a Public Limited Company on September 19, 2017.
Presently, the Company is engaged in manufacturing of specialized chemicals. Initially, the control & management of the Company was with Mr. Bharat Rasiklal Chokshi, Mr Saumil Bharatbhai Chokshi, Mr. Sudhakarbhai Chhotabhai Patel and Mr. Shalin Bharat Chokshi who were the subscribers to the Memorandum of Association.
Since, April 01, 2013 the control & management was completely taken over by Mr. Shalin Sudhakarbhai Patel and Mr. Shalin Bharat Chokshi. The Company started construction of its first plant for Thiophene Derivatives in 2013.

FAQs for the comparison of Anlon Healthcare Ltd and Arvee Laboratories (India) Ltd

Which company has a larger market capitalization, Anlon Healthcare Ltd or Arvee Laboratories (India) Ltd?

Market cap of Anlon Healthcare Ltd is 644 Cr while Market cap of Arvee Laboratories (India) Ltd is 161 Cr

What are the key factors driving the stock performance of Anlon Healthcare Ltd and Arvee Laboratories (India) Ltd?

The stock performance of Anlon Healthcare Ltd and Arvee Laboratories (India) Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Anlon Healthcare Ltd and Arvee Laboratories (India) Ltd?

As of March 22, 2026, the Anlon Healthcare Ltd stock price is INR ₹121.35. On the other hand, Arvee Laboratories (India) Ltd stock price is INR ₹146.16.

How do dividend payouts of Anlon Healthcare Ltd and Arvee Laboratories (India) Ltd compare?

To compare the dividend payouts of Anlon Healthcare Ltd and Arvee Laboratories (India) Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.